Acalabrutinib
(Update) Acalabrutinib in CLL and MCL
Obinutuzumab
Zanubrutinib
Update Venetoclax in CLL
NCCN Guidelines for Patients for CLL
JADPRO Roundtable Series: Best Practices in the Use of BTK Inhibitors in CLL
Leukemia & Lymphoma Society
Cancer.gov